Tessa E van Riemsdijk

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Angiotensin Converting Enzyme

Oxide Nanoparticles

Stem Cell Transplantation

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology 89 (4) (2023)
Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology (2023)
Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology (2023)
Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology 89 (4) (2023)